EXAS vs STAA · rev $2.76B vs rev $313.9M
EXACT Sciences Corporation (EXAS) versus STAAR Surgical Company (STAA) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported STAA revenue for 2024-12-27 was $313.9M. Net income was -$20.2M. Revenue was down 2.6% from 2023-12-29 to 2024-12-27. STAA currently screens at market cap $1.45B.
EXAS currently screens at market cap $20.03B. STAA currently screens at market cap $1.45B.
Not investment advice. Open the EXAS and STAA stock pages for the full models.
Not investment advice.